Trust Company of the South’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Sell
9,143
-79
-0.9% -$18.4K 0.33% 32
2026
Q1
$2.25M Sell
9,222
-148
-2% -$34.5K 0.36% 30
2025
Q4
$1.94M Sell
9,370
-568
-6% -$112K 0.31% 34
2025
Q3
$1.84M Buy
9,938
+44
+0.4% +$7.54K 0.31% 34
2025
Q2
$1.51M Buy
9,894
+22
+0.2% +$3.38K 0.27% 39
2025
Q1
$1.64M Buy
9,872
+200
+2% +$31.3K 0.34% 33
2024
Q4
$1.4M Buy
9,672
+470
+5% +$72.8K 0.28% 38
2024
Q3
$1.49M Buy
9,202
+35
+0.4% +$5.58K 0.32% 33
2024
Q2
$1.34M Sell
9,167
-284
-3% -$42.2K 0.32% 31
2024
Q1
$1.5M Sell
9,451
-2,141
-18% -$341K 0.35% 31
2023
Q4
$1.82M Buy
+11,592
New +$1.78M 0.48% 23

Other funds holding JNJ

Trust Company of the South's JNJ Position: Q2 2026 in Review

Trust Company of the South reduced its Johnson & Johnson (JNJ) stake by 0.86% in Q2 2026, selling an estimated $18.4K and leaving 9,143 shares worth $2.32M. The position accounts for 0.33% of the portfolio, ranked #32.

Trust Company of the South first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Trust Company of the South held 9,143 shares of Johnson & Johnson worth $2.32M as of Q2 2026.
  • Trust Company of the South sold 79 Johnson & Johnson shares in Q2 2026, an estimated $18.4K.
  • Johnson & Johnson made up 0.33% of Trust Company of the South's portfolio in Q2 2026, its #32 holding.
  • Trust Company of the South first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Trust Company of the South's 13F filing for Q2 2026, filed 1 Jul 2026.